Literature DB >> 9181267

Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study.

M G Modena1, N Muia, F A Sgura, R Molinari, A Castella, R Rossi.   

Abstract

HYPOTHESIS: This study was undertaken to determine whether echo-derived left atrial dimension and other echocardiographic, clinical, and hemodynamic parameters detected at the time of entry into the study may influence prognosis in patients with dilated cardiomyopathy during a long-term follow-up.
METHODS: This was a prospective cohort analysis of 123 patients with dilated cardiomyopathy. Clinical evaluation, chest x-ray, M-mode and two-dimensional echocardiogram, exercise test, 72-h ambulatory electrocardiogram monitoring, and cardiac catheterization study were performed in all patients. The study was divided into two phases: in the first phase, patients were divided into two groups according to the left atrial size (> or = 45 mm; < 45 mm), with cardiac death as the end point. In the second phase, all patients were further divided into two groups according to their clinical course. A multivariate analysis was performed to determine independent correlated parameters of cardiac mortality and overall clinical outcome.
RESULTS: Cardiac mortality rate was 47.9%: 29% in the group without left atrial dilation and 54.3% in the group with dilated left atrium. Multivariate analysis revealed that left atrium > or = 45 mm, New York Heart Association functional classes III/IV, and the presence of one or more episodes of ventricular tachycardia at Holter monitoring were independent predictors of cardiac mortality, while left atrium > or = 45 mm, left ventricular end-diastolic pressure > 17 mmHg, and exercise tolerance < or = 15 min were independent predictors of poor clinical outcome.
CONCLUSIONS: Our results revealed that left atrial size is the principal independent predictor of prognosis in patients with dilated cardiomyopathy in that patients with left atrial dilation had an increase in mortality and a worse clinical outcome compared with those without left atrial dilation.

Entities:  

Mesh:

Year:  1997        PMID: 9181267      PMCID: PMC6655314          DOI: 10.1002/clc.4960200609

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  38 in total

1.  LEFT RETROGRADE CARDIOANGIOGRAPHY IN ACQUIRED CARDIAC DISEASE: TECHNIC, INDICATIONS AND INTERPRETATIONS IN 700 CASES.

Authors:  R D SELLERS; M J LEVY; K AMPLATZ; C W LILLEHEI
Journal:  Am J Cardiol       Date:  1964-10       Impact factor: 2.778

Review 2.  The heart in hypertension.

Authors:  E D Frohlich; C Apstein; A V Chobanian; R B Devereux; H P Dustan; V Dzau; F Fauad-Tarazi; M J Horan; M Marcus; B Massie
Journal:  N Engl J Med       Date:  1992-10-01       Impact factor: 91.245

3.  Echocardiographic analysis of left atrial size before and after operation in mitral valve disease.

Authors:  M V Sherrid; R D Clark; K Cohn
Journal:  Am J Cardiol       Date:  1979-02       Impact factor: 2.778

Review 4.  Left ventricular compliance: mechanisms and clinical implications.

Authors:  W H Gaasch; H J Levine; M A Quinones; J K Alexander
Journal:  Am J Cardiol       Date:  1976-11-04       Impact factor: 2.778

5.  The epidemiology of idiopathic dilated cardiomyopathy in a biracial community.

Authors:  S S Coughlin; M Szklo; K Baughman; T A Pearson
Journal:  Am J Epidemiol       Date:  1990-01       Impact factor: 4.897

6.  Mortality in heart failure: clinical variables of prognostic value.

Authors:  J G Cleland; H J Dargie; I Ford
Journal:  Br Heart J       Date:  1987-12

7.  Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography.

Authors:  R J Lee; T Bartzokis; T K Yeoh; H R Grogin; D Choi; I Schnittger
Journal:  Stroke       Date:  1991-06       Impact factor: 7.914

8.  The clinical course of idiopathic dilated cardiomyopathy. A population-based study.

Authors:  D D Sugrue; R J Rodeheffer; M B Codd; D J Ballard; V Fuster; B J Gersh
Journal:  Ann Intern Med       Date:  1992-07-15       Impact factor: 25.391

9.  Prediction of outcome in late-stage cardiomyopathy.

Authors:  T L Kelly; R Cremo; C Nielsen; R Shabetai
Journal:  Am Heart J       Date:  1990-05       Impact factor: 4.749

10.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

View more
  28 in total

Review 1.  Modulation of left atrial function by ventricular filling impairment.

Authors:  A Rossi; P Zardini; P Marino
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

2.  Effects of obstructive sleep apnea treatment on left atrial volume and left atrial volume index.

Authors:  Akram Khan; Faisal Latif; Beau Hawkins; Maroun Tawk; Chittur A Sivaram; Gary Kinasewitz
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

3.  Left atrial volume assessment in atrial fibrillation using multimodality imaging: a comparison of echocardiography, invasive three-dimensional CARTO and cardiac magnetic resonance imaging.

Authors:  Mark G Rabbat; David Wilber; Kevin Thomas; Owais Malick; Atif Bashir; Anoop Agrawal; Santanu Biswas; Thriveni Sanagala; Mushabbar A Syed
Journal:  Int J Cardiovasc Imaging       Date:  2015-03-12       Impact factor: 2.357

Review 4.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

5.  Prognostic role of echocardiographic and hematologic parameters in heart failure patients complicated with incidental pleural effusion diagnosed during echocardiographic evaluation.

Authors:  Muhammed Oylumlu; Vedat Davutoglu; Murat Sucu; Suleyman Ercan; Orhan Ozer; Murat Yuce
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-08       Impact factor: 2.357

6.  Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography.

Authors:  Cesare Russo; Rebecca T Hahn; Zhezhen Jin; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  J Am Soc Echocardiogr       Date:  2010-07-21       Impact factor: 5.251

7.  Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure.

Authors:  R J Viotti; C Vigliano; S Laucella; B Lococo; M Petti; G Bertocchi; B Ruiz Vera; H Armenti
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

8.  Left atrial volume measurement with automated border detection by 3-dimensional echocardiography: comparison with Magnetic Resonance Imaging.

Authors:  Ramin Artang; Raymond Q Migrino; Leanne Harmann; Mark Bowers; Timothy D Woods
Journal:  Cardiovasc Ultrasound       Date:  2009-03-31       Impact factor: 2.062

9.  The effects of short time right ventricular pacing on left atrial mechanical functions.

Authors:  Oyku Gulmez; Ilyas Atar; Elif Sade; I Asli Atar; Cagatay Ertan; Haldun Muderrisoglu; Bulent Ozin
Journal:  Indian Pacing Electrophysiol J       Date:  2009-05-15

10.  Echocardiographic assessments of left atrial strain and volume in healthy patients and patients with mitral valvular heart disease by tissue Doppler imaging and 3-dimensional echocardiography.

Authors:  Mi-Seung Shin; Bong Roung Kim; Kyu Jin Oh; Jeong Min Bong; Wook-Jin Chung; Woong Chol Kang; Seung Hwan Han; Chan Il Moon; Tae Hoon Ahn; In Suck Choi; Eak Kyun Shin
Journal:  Korean Circ J       Date:  2009-07-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.